Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dermex AB
AB
Active
Org 5590088513
Islandsgatan 8
Medical specialists activities · NACE 8622
Est. 2015
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 284K
-39% vs 2023
EBITDA margin
83.3%
-44% vs 2023
Equity ratio
72.7%
Financial strength
Net profit 2024
SEK 155K
-55% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 284K
-39%
EBITDA
SEK 237K
-44%
Net profit
SEK 155K
-55%
Total assets
SEK 1,2M
+16%
Equity
SEK 888K
-5%
Employees
1
—
Company information
Legal name
Dermex AB
Org number
5590088513
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
26 mars 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom hälso- och sjukvård, medicinsk utbildning och forskning samt därmed förenlig verksamhet.
Contact
Address
Islandsgatan 8
Email
ola.rollman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
315
396
417
468
284
Staff expenses
—
—
−21
−21
−12
EBITDA
273
332
363
422
237
Depreciation & amort.
−0
−0
—
—
—
EBIT
273
332
363
422
237
Net financials
—
—
0
10
26
Profit before tax
273
333
363
432
197
Tax
−60
−70
−76
−89
−42
Net profit
213
263
287
342
155
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
932
782
890
1 050
1 223
Equity
828
690
791
938
888
Long-term debt
0
0
—
—
—
Short-term debt
104
92
99
112
268
Total debt
104
92
99
112
268
Financial ratios
5-year trend
EBITDA margin
83.3%
This company
15.8%
Market median
+427% vs market
2020
2024
Equity ratio
72.7%
This company
38.2%
Market median
+90% vs market
2020
2024
Return on equity
17.5%
This company
18.4%
Market median
+5% vs market
2020
2024
Net profit margin
54.5%
This company
8.1%
Market median
+573% vs market
2020
2024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
2020
2024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
NR
Nils-Ola Rollman
Board of Directors
2022
KM
Kerstin Maria Rollman
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dermex AB also hold positions in
0
other companies.
Person
Role here
Other companies
Nils-Ola Rollman
Board of Directors
0 companies
Kerstin Maria Rollman
Deputy Board Member
0 companies